Cargando…
Differential enrichment of H3K9me3 in intrahepatic cholangiocarcinoma
BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is a malignant tumor, which poses a serious threat to human health. Histone 3 lysine 9 trimethylation (H3K9me3) is a post-translational modification involved in regulating a broad range of biological processes and has been considered as potential the...
Autores principales: | Hu, Sheng, Wang, Xuejun, Wang, Tao, Wang, Lianmin, Liu, Lixin, Ren, Wenjun, Liu, Xiaoyong, Zhang, Weihan, Liao, Weiran, Liao, Zhoujun, Zou, Renchao, Zhang, Xiaowen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414128/ https://www.ncbi.nlm.nih.gov/pubmed/36028818 http://dx.doi.org/10.1186/s12920-022-01338-1 |
Ejemplares similares
-
Dual-Specificity Phosphatase 11 Is a Prognostic Biomarker of Intrahepatic Cholangiocarcinoma
por: Xu, Lin, et al.
Publicado: (2021) -
Insights into the role of STAT3 in intrahepatic cholangiocarcinoma
por: Yang, Ranzhiqiang, et al.
Publicado: (2022) -
Proposal for a new N-stage classification system for intrahepatic cholangiocarcinoma
por: Liao, Shan, et al.
Publicado: (2023) -
Overexpression of UHRF2 in intrahepatic cholangiocarcinoma and its clinical significance
por: Peng, Rui, et al.
Publicado: (2017) -
Prognostic significance of the neutrophil-to-lymphocyte ratio with distal cholangiocarcinoma patients
por: Ji, Fengming, et al.
Publicado: (2020)